论文部分内容阅读
作者用SCC-Ag检测术后头颈部鳞癌和粘表患者。发现已转移到淋巴结或肺的鳞癌患者中,无论有无局部复发,其血清中SCC-Ag的含量均较高,通常大于1.7ng/ml;与之对照的是,术后一年无复发无转移的患者,其血清中SCC-Ag浓度小于1.7ng/ml,提示预后良好的病人血清中,SCC-Ag的含量较低;反之,含量较高。因此,作者认为SCC-Ag是早期诊断鳞癌,判断
The authors used SCC-Ag to detect postoperative head and neck squamous cell carcinoma and sticky table patients. In patients with squamous cell carcinoma who have metastasized to lymph nodes or lungs, the serum SCC-Ag content is higher, usually greater than 1.7 ng/ml, regardless of local recurrence. In contrast, no recurrence occurs in one year after surgery. In patients without metastasis, the serum SCC-Ag concentration was less than 1.7 ng/ml, suggesting that the serum level of SCC-Ag was lower in patients with good prognosis; Therefore, the author believes that SCC-Ag is an early diagnosis of squamous cell carcinoma, judging